Group 1 - The A-share market saw all three major indices turn negative, but the technology sector showed relative strength, particularly in AI applications and software development, with significant gains in stocks like Yonyou Network and Zhongke Xingtu [1] - NVIDIA and Eli Lilly announced a partnership to invest $1 billion over five years to establish a joint research lab in the San Francisco Bay Area, aimed at accelerating AI applications in the pharmaceutical industry [1] - According to Everbright Securities, the application of AI in the healthcare sector is entering a critical phase of commercialization, with innovative business models transforming low-frequency medical visits into high-frequency health management needs [1] Group 2 - The AI ETF (515070) tracks the CS AI Theme Index (930713), selecting stocks that provide technology, basic resources, and applications in the AI sector, focusing on the midstream and upstream of the AI industry chain [2] - The top ten weighted stocks in the AI ETF include leading domestic technology companies such as Zhongji Xuchuang, Xinyi Sheng, and Keda Xunfei [2] Group 3 - Related products include the AI ETF (515070), Huaxia CSI AI Theme ETF Link A (008585), and Huaxia CSI AI Theme ETF Link C (008586) [3]
英伟达合作建设AI药物实验室,人工智能AIETF(515070)持仓股中科星图大涨超11%